Syringe Services Programs
The National Harm Reduction Coalition estimates that approximately a
quarter of people living with HIV/AIDS also require treatment for a substance use disorder. With the opioid
crisis impacting many rural communities in the U.S., the risk for new HIV infections due to injection drug use
has become an even larger threat. A CDC
vulnerability assessment conducted in 2018 identified 220 counties most at risk for the rapid spread of
HIV among people who inject drugs. In particular, Central Appalachia had the most counties considered highly
Harm reduction is a strategy that aims to reduce the harms associated with the use of drugs, including the risk
of acquiring HIV or other blood-borne infections. Harm reduction strategies may include implementing syringe
exchange programs (also known as syringe services programs or SSPs) and providing education and treatment for
Instead of focusing on preventing drug use, harm reduction offers services for drug users to reduce the
additional harms associated with using drugs. The World
Health Organization strongly recommends harm reduction as an evidence-based model for the prevention,
treatment, and care of HIV. In addition, the HIV
National Strategic Plan: A Roadmap to End the Epidemic for the U.S. states that interventions that
increase access to sterile needles and syringes among people who inject drugs can reduce the risk of acquiring
HIV. Decades of research on SSPs has shown that they are safe and cost-effective, prevent the spread of diseases
such as HIV and viral hepatitis, and do not increase drug use.
Several states have implemented laws that mandate syringe exchange programs. For example, in 1997, New Mexico
passed the Harm Reduction Act, which required the New Mexico Department of Health to administer a harm reduction program with a syringe exchange
component. As of 2015, Kentucky became the first state in the southern portion of the U.S. to legalize SSPs.
Since 2015, the number of states with active SSPs continues to grow. The North American Syringe Exchange Network
(NASEN) provides a directory of SSPs offering an exchange
program for individuals.
NASEN is a national network of SSPs that is one of two harm reduction programs part of the Dave Purchase Project. Dave Purchase is believed
to have started the first harm reduction program in Tacoma, Washington in 1988 to help prevent HIV
transmission. The Dave Purchase Project now includes NASEN, which includes a
vast purchasing network that works to buy low price syringes to supply to SSPs around the country, and the Tacoma Needle Exchange initiative. The Tacoma
Needle Exchange works with communities to use a harm reduction approach to HIV prevention, providing people with
supplies such as clean syringes, and other services that help residents lead safe and healthy lives.
For more information about harm reduction models that have been implemented in rural communities for substance
use disorders, see the Harm Reduction Models
section of the Rural Prevention and Treatment of Substance Use Disorders Toolkit.
Examples of Rural Syringe Exchange Programs and Treatment for Drug Use and Dependence:
Open Aid Alliance is an organization based in western Montana
that works to reach and engage underserved populations to prevent the spread of HIV, hepatitis C, and other
sexually transmitted infections through harm reduction. The main areas of focus include education, testing,
and screening. An important element of this organization is its syringe exchange program, which has provided
thousands of new syringes and supplies to people. This exchange program was one of the first open syringe
exchange programs operating in the state.
Southern Tier AIDS Program (STAP) is an organization providing
comprehensive HIV/AIDS prevention and treatment services to people who are living in the southern portion of
the state of New York, regardless of ability to pay. Some of the prevention services offered to clients
include a focus on substance use disorder prevention and treatment, as well as a STAP syringe exchange program where people can
anonymously receive sterile syringes. In addition, the organization provides educational classes about how
to prevent opioid overdose, as well as other information and referrals for people with substance use
Health Services Center (HSC) administers substance use disorder
treatment services for people who are both HIV-positive and -negative. HSC integrates substance use disorder
treatment into HIV treatment to decrease barriers to care. Strong case management services,
transportation support, medication reminders, and free medication all help clients address multiple needs so
that they can focus on staying healthy. Two featured programs include the Corrections and Offender Re-Entry
(CORE) Program and Behavioral Day Treatment (BDT). CORE is an outpatient treatment program for adults
recently released from a jail or prison. The program consists of comprehensive treatment and HIV prevention
and education services and requires twice-weekly group meetings. BDT is an in-depth treatment program that
requires meetings four times a week for 20 weeks.
HIV Alliance is a nonprofit organization in Oregon that offers many
prevention and treatment services. The organization promotes a philosophy of harm reduction and offers both
secure locations for syringe drop-off in the community as well as pickup services for used syringes when
needed. In several Oregon counties, HIV Alliance is one of the only organizations that offers syringe
The Deschutes County Syringe
Exchange Program is administered through Deschutes County Health Services in Oregon. It provides
syringe drop boxes and new sterile syringes to members of the community in both Bend and rural Redmond. The
program also educates the community about overdose prevention as well as how to prevent the spread of
infections through needle use.
Santa Fe Mountain Center offers harm
reduction programming with funding through the New Mexico Department of Health HIV/AIDS Infectious Disease
Bureau. Part of this programming includes a very active syringe exchange program which is one of the largest
in the U.S., providing services throughout the rural county of Rio Arriba, New Mexico. In 2015, Santa Fe
Mountain Center exchanged over 1 million syringes. The harm reduction program is predominantly mobile and
the staff travels hundreds of miles each week to visit homes and work with people in villages throughout the
county. The program also provides counseling, rapid HIV testing, naloxone distribution for overdose
prevention, and food assistance to people based on need.
Considerations for Implementation
Harm reduction programs may be controversial and stigmatized when implemented in rural communities. Principles
of harm reduction include respecting the decisions of people and offering solutions that are supportive of these
decisions. The high-risk practices of people who inject drugs can also make this population especially
challenging to locate and engage in prevention activities in general.
Prescription drug misuse and injection drug use are prevalent nationwide,
including in rural communities where access to substance use disorder treatment services may be more limited
with fewer providers able to administer treatment.
Injection drug users often face additional social issues, such as homelessness, a history of trauma,
incarceration, poverty, and a lack of health insurance, which can hinder their ability to stay engaged in both
prevention and care. In addition, the use of injection drugs can increase other risky behaviors, which can pose
challenges for retention in programs. Since drug use is stigmatized and also criminalized in communities, it can
prevent individuals from utilizing treatment services for fear of the repercussions.
To offset many of these retention and engagement challenges, some rural communities have decided, when possible,
to co-locate services to provide substance use disorder treatment, HIV/hepatitis C testing, a syringe exchange,
and HIV/AIDS treatment in the same location. Collaborations are essential for referrals to programs and to help
provide more comprehensive services to communities in need.
Funding continues to be a challenge for many substance use disorder treatment programs. Before 2015, federal
funding could not be used to implement syringe exchange programs. In 2015, the Consolidated Appropriations Act,
2016 (Pub. L. 114-113) revised this longstanding ban, and the U.S. Department of Health and Human Services has
since issued guidance for use of federal
funds in order to implement and expand syringe exchange programs. More recently, the Consolidated
Appropriations Act of 2018 allows use of federal resources to fund certain pieces of SSP implementation.
Communities implementing this model may consider seeking foundation and state/local funding to support these
programs as well.
Health Rankings & Roadmaps offers additional evidence, implementation examples, and resources for
communities implementing SSPs as a harm reduction strategy to prevent HIV.
Resources to Learn More
Directory of Syringe Exchange Programs
Offers a resource and searchable database of active syringe exchange programs throughout the U.S. Users can
search the directory by ZIP code, state, or landmark, and find additional information about nearby programs,
such as contact information and location.
Organization(s): North American Syringe Exchange Network
Harm Reduction Coalition: Syringe Access
Provides key information about the benefits of syringe access programs in reducing transmission of HIV and
hepatitis C. Features a resource library of fact sheets, webinars, and guides promoting health for persons
affected by drug use including other harm reduction strategies to lower the incidence of HIV.
Organization(s): National Harm Reduction Coalition
Discusses harm reduction and its impact on HIV prevention around the world. Includes cited research describing
the different types of programs using harm reduction strategies and the barriers to these programs for HIV
and Injection Drug Use
Provides information and facts about HIV and injection drug use in the U.S. Describes HIV prevention challenges
that arise when targeting individuals that share syringes and use injection drugs.
Organization(s): Centers for Disease Control and Prevention (CDC)
Describes syringe services programs (SSPs) and how they can reduce HIV infections. Provides updated guidance
developed from several federal agencies on the use of federal funds for implementing SSPs in communities.
Organization(s): HIV.gov, U.S. Department of Health & Human Services